Skip to main content

Breadcrumb

  1. Home

An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors

An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors

A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3

Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay

PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors

Comparison of PD-L1 expression in primary and metastatic lung cancer biopsies

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Comparison of PD-L1 expression in primary and metastatic lung cancer biopsies

Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer

Spatial analytics of the tumor microenvironment on double stained immunohistochemistry images using deep learning

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial analytics of the tumor microenvironment on double stained immunohistochemistry images using deep learning

Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 64
  • Page 65
  • Page 66
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • …
  • Next page Next
  • Last page Last
Subscribe to